Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
3.560
+0.070 (2.01%)
Nov 20, 2024, 4:00 PM EST - Market closed
Accolade Revenue
Accolade had revenue of $106.36M in the quarter ending August 31, 2024, with 9.80% growth. This brings the company's revenue in the last twelve months to $441.03M, up 16.04% year-over-year. In the fiscal year ending February 29, 2024, Accolade had annual revenue of $414.29M with 14.09% growth.
Revenue (ttm)
$441.03M
Revenue Growth
+16.04%
P/S Ratio
0.62
Revenue / Employee
$183,762
Employees
2,400
Market Cap
286.71M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AngioDynamics | 292.73M |
Vanda Pharmaceuticals | 190.86M |
Voyager Therapeutics | 163.78M |
NeuroPace | 76.45M |
iTeos Therapeutics | 35.00M |
Mersana Therapeutics | 34.84M |
Eton Pharmaceuticals | 34.68M |
ACCD News
- 7 days ago - Accolade To Present at Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating - Business Wire
- 5 weeks ago - Accolade Welcomes Renalogic to Trusted Partner Ecosystem - PRNewsWire
- 6 weeks ago - Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30 - GuruFocus
- 6 weeks ago - Accolade Announces Results for Fiscal Second Quarter 2025 - GlobeNewsWire
- 6 weeks ago - Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
- 6 weeks ago - Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings - Benzinga